- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/24 - Interleukins
Patent holdings for IPC class C12N 15/24
Total number of patents in this class: 281
10-year publication summary
16
|
8
|
14
|
18
|
17
|
27
|
21
|
26
|
17
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
ZymoGenetics, LLC | 16 |
8 |
The Trustees of the University of Pennsylvania | 4304 |
7 |
Regeneron Pharmaceuticals, Inc. | 4223 |
6 |
Altor BioScience, LLC | 74 |
6 |
Joint Stock Company "BIOCAD" | 183 |
5 |
Noile-immune Biotech Inc. | 34 |
5 |
Board of Regents, The University of Texas System | 5745 |
4 |
National University Corporation Tottori University | 204 |
4 |
National University of Singapore | 2424 |
4 |
Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 1960 |
4 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
4 |
University Health Network | 1025 |
4 |
Yale University | 2356 |
4 |
Nanjing Bioheng Biotech Co., Ltd | 44 |
4 |
Novartis AG | 10927 |
3 |
Boehringer Ingelheim International GmbH | 4701 |
3 |
Merck Patent GmbH | 5840 |
3 |
Children's Healthcare of Atlanta, Inc. | 242 |
3 |
Cytheris | 4 |
3 |
Emory University | 1618 |
3 |
Other owners | 194 |